A Virus Used as a Cancer Treatment: Melanoma and Oncolytic Therapy

"A virus that treats cancer" sounds like a headline that must be exaggerating. It is not, though it is easy to misread.

The FDA keeps a running list of cancer drug approvals. We read it on September 24, 2026. An entry dated August 6, 2026 lists vusolimogene oderparepvec-wtpg (brand name Tudriqev). The list describes it as a virus therapy that has been changed in a lab to attack cancer. It got accelerated approval. It is for use with a drug called nivolumab, in advanced melanoma of the skin that surgery cannot remove.

What melanoma is

The National Cancer Institute describes melanoma as "a disease in which malignant (cancer) cells form in melanocytes (cells that color the skin)." Melanocytes are the cells that make the pigment in skin.

Unresectable means surgery cannot remove the cancer. NCI groups advanced melanoma as "stage III melanoma that cannot be removed by surgery, stage IV melanoma, and recurrent melanoma." Stage IV means it has spread to distant parts of the body, such as the lungs, liver, brain or bones.

What an oncolytic virus is

An oncolytic virus therapy uses a virus that has been changed in a lab. It grows inside cancer cells and not in healthy ones. The idea has two parts. First, the virus harms the cancer cells it grows in. Second, the damage it causes makes the immune system notice the tumor. The immune system may have been ignoring it before.

This is not brand new in melanoma. NCI's melanoma treatment page already lists oncolytic virus therapy among the treatment types, naming "talimogene laherparepvec injected into the tumor." Treatments like this are usually injected right into a tumor. They are not taken as a pill or given through a drip into a vein.

Why it is paired with another drug

The August listing is for use with nivolumab. Nivolumab is an immune checkpoint inhibitor — NCI lists it among the immunotherapy drugs used in melanoma.

NCI explains the category this way: "Immune checkpoint inhibitors are drugs that block immune checkpoints... By blocking them, these drugs allow immune cells to respond more strongly to cancer." Checkpoints are brakes. They keep the immune system from attacking the body's own tissue. Some cancers use them to hide.

Using the two together makes sense in theory. One treatment makes the tumor easier to see. The other takes the brakes off the immune response. But making sense in theory is not the same as proven.

Why "accelerated" matters here

An accelerated approval is not a lesser approval. It is an earlier one. It lets a drug reach patients based on an early sign that it may help. Often that sign is whether tumors shrank, and for how long. It comes before full proof that people lived longer or better.

Confirming studies are meant to continue afterwards. Sometimes they confirm the benefit. Sometimes they do not, and the approval for that use is withdrawn.

So here is a careful way to read this headline. A new option exists for a specific group of people with advanced melanoma. The full evidence is still being gathered.

What this approval cannot tell you

• It cannot tell you how long anyone lives on it. That is the question an accelerated approval is granted before answering. We did not read trial results for this page.
• It cannot tell you whether it fits a particular person. It is for advanced melanoma of the skin that surgery cannot remove. It is not for early melanoma that has been removed.
• It cannot tell you what treatment is like. Immunotherapy has real side effects. NCI notes that many "happen when the immune system that has been revved-up to act against the cancer also acts against healthy cells and tissues in your body." An approval listing says nothing about that.
• It does not support any home remedy involving viruses or infections. This virus is changed in a lab and given with medical care. It has nothing to do with catching a virus. Nothing here supports the idea that infections cure or cause cancer in general.
• It changes nothing about skin checks or sun protection. This is a treatment for advanced disease, not a reason to worry less about prevention or early detection.

What to ask a healthcare team

• Is my melanoma at a stage where a treatment like this would even be considered?
• How would it be given, and how often would I need to come in?
• What side effects would we be watching for, and which ones should I call about?
• Is there a clinical trial that might be relevant to my situation?

How this article was prepared

An AI-assisted editorial system helped prepare this page. It used the FDA's list of cancer drug approvals. It also used NCI patient pages on melanoma treatment and immunotherapy. Each was opened on the source-check date shown above. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.